Jared Teo

Inbound Health provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. The companys flexible partnership structure enables customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area. To date, more than 4,200 patients across 185 primary diagnoses have been cared for through the Inbound Health platform, which has been operational in Allina Health’s service area since May 2020. The program has allowed Allina Health to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program.

Ajax Health deploys capital and leverages operational experience to accelerate healthcare innovation across medical devices, digital health, healthcare services and biotechnology. We partner with entrepreneurs across all stages of a company's lifecycle and leverage deep domain expertise to support business strategy, clinical & regulatory, R&D and M&A.

Who We Are We’re a team of real people with families just like yours, so we get it. We understand how hard it can be to navigate caring for a loved one or worrying about your own aging. That’s why we do what we do. We exist to ease the struggles of caregiving and recovery, and to provide you and your family with a safe, healthy, and happy lifestyle, no matter the circumstances. We want to make sure you or your loved ones can remain at home and maintain independence for as long as possible. Aging or illness shouldn’t keep you from enjoying life and our knowledgeable and reliable team is always there to make your day-to-day possible. We’re committed to providing care of the highest standard and treat our patients with the utmost dignity. You don’t have to do this alone. We are always here for you. We are a licensed home health agency, not a nurse registry. We are Medicare-certified and CHAP-accredited. What We Believe Our patients are an extension of our family and we want to care for you and your loved ones the same way we’d hope to be cared for ourselves. Health, safety, comfort, and companionship are our top priorities. Our staff is educated and passionate about quality care and we are committed to doing the right thing, no matter what. Whether your needs are simple or more complex, non-medical or skilled care, we’re here to make your life easier. You and your family deserve a trusted resource that you can rely on in times of need and we are here to be that resource for you.

CleanSlate is a national medical group that provides physician-led, office-based treatment for individuals suffering from mental and behavioral health diagnoses, as well as opioid and alcohol use disorders. Founded in 2009 in response to the growing opioid epidemic, CleanSlate has grown to become an industry leader in high-quality, evidence-based care, providing medication-assisted treatment and related mental and behavioral therapies to those suffering from the chronic disease of addiction. CleanSlate’s extensive footprint of centers is growing rapidly to meet the demand for its medical services in states struggling with the opioid crisis throughout the country. To learn more, visit www.CleanSlateCenters.com.

mPulse, a leading Health Experience and Insights company, is transforming consumer experiences to deliver better, more equitable health outcomes.By combining AI-powered analytics, omnichannel outreach, and digital health navigation technology, mPulse creates personalized health journeys and provides advanced insights to facilitate collaboration across the healthcare ecosystem. With over a decade of experience and more than 4 billion consumer-related transactions annually, mPulse is the trusted health experience and insights partner for over 450 healthcare organizations. To learn more, visit mpulse.com or reach out to us directly at info@mpulse.com.

At PipelineRx our vision is for every provider and every patient to have access to high-quality pharmacy services anytime, anywhere. We have been on a mission to optimize and transform pharmacy since 2009. Today, our flexible, scalable medication management platform and supporting services are driving a more efficient pharmacy for over 500 hospitals and health systems across the U.S and Canada. Making patient-driven pharmacy care a reality is why we continuously hone our technology and services each day. As progress continues into personalized medicine, the specialized knowledge of the pharmacist will play a critical role. That is why now, more than ever, we’re focused on making pharmacy accessible - anytime, anywhere - so patients can live longer, healthier lives. For more information, visit pipelinerx.com.

Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.

Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by top-tier venture investors Athyrium Capital Management, Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures.

Inbound Health provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. The companys flexible partnership structure enables customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area. To date, more than 4,200 patients across 185 primary diagnoses have been cared for through the Inbound Health platform, which has been operational in Allina Health’s service area since May 2020. The program has allowed Allina Health to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program.

Ajax Health deploys capital and leverages operational experience to accelerate healthcare innovation across medical devices, digital health, healthcare services and biotechnology. We partner with entrepreneurs across all stages of a company's lifecycle and leverage deep domain expertise to support business strategy, clinical & regulatory, R&D and M&A.